Overview

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration

Status:
Unknown status

Trial end date:
2014-02-01

Target enrollment:

Participant gender:

Summary

This study is designed to investigate the pharmacokinetic drug interaction and safety after oral administration of Udenafil(DA-8159) and Bosentan in healthy volunteers. Design: Randomized, open-label, multiple-dose, three-treatment, three-period, six-sequence, Williams design Investigational Product: Udenafil, Bosentan

Phase:

Phase 1

Details

Lead Sponsor:

Dong-A Pharmaceutical Co., Ltd.

Collaborator:

Dong-A ST Co., Ltd.

Treatments:

Bosentan
Udenafil